Clinical trials
Phase 2/3 trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
293 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 3 |
| 2003 | 2 |
| 2004 | 3 |
| 2005 | 9 |
| 2006 | 7 |
| 2007 | 7 |
| 2008 | 17 |
| 2009 | 12 |
| 2010 | 13 |
| 2011 | 8 |
| 2012 | 10 |
| 2013 | 11 |
| 2014 | 6 |
| 2015 | 8 |
| 2016 | 9 |
| 2017 | 8 |
| 2018 | 21 |
| 2019 | 16 |
| 2020 | 29 |
| 2021 | 31 |
| 2022 | 14 |
| 2023 | 10 |
| 2024 | 6 |
| 2025 | 18 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 139 |
| Unknown status | 45 |
| Recruiting | 38 |
| Terminated | 35 |
| Active, not recruiting | 25 |
| Suspended | 5 |
| Enrolling by invitation | 3 |
| Not yet recruiting | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Sao Paulo | 17 |
| Azidus Brasil | 11 |
| Hospital de Clinicas de Porto Alegre | 10 |
| Bristol-Myers Squibb | 9 |
| Pfizer | 9 |
| Federal University of São Paulo | 8 |
| Universidade Federal do Piauí | 8 |
| University of Sao Paulo General Hospital | 8 |
| Merck Sharp & Dohme LLC | 6 |
| Sanofi | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 33 |
| Heart Failure | 11 |
| Neoplasm Metastasis | 7 |
| Breast Neoplasms | 6 |
| Carcinoma, Non-Small-Cell Lung | 6 |
| Coronavirus Infections | 6 |
| Alzheimer Disease | 5 |
| Coronary Artery Disease | 5 |
| Inflammation | 5 |
| Stroke | 5 |
Trials
Showing 76 to 100 of 293. Each trial links to its page on Pharma Observatory.
193 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.